Immunogenicity study of dna vaccine and
dna vaccine carrier expressing vp1 of enterovirus
71 in the prime boost vaccination strategy

QR Code

Immunogenicity study of dna vaccine and dna vaccine carrier expressing vp1 of enterovirus 71 in the prime boost vaccination strategy

Enterovirus 71 {EV71) is a highly infectious causative agent of hand, foot and mouth disease {HFMD) in children and which could lead to severe neurological complications. In Malaysia, the first epidemic occurred in 1997 in Sarawak and caused 34 deaths due to severe neurological syndrome. There is...

Full description

Bibliographic Details
Main Author:	Nur Ayuni, Kadir
Format:	Thesis
Language:	English
Published:	2008
Subjects:	R Medicine (General)
Online Access:	http://eprints.usm.my/52096/ http://eprints.usm.my/52096/1/NUR%20AYUNI%20KADIR%20-%2024%20pages.pdf

Similar Items

Construction Of Recombinant Bcg Expressing The Vp1 Antigen Of Enterovirus 71 For The Development Of A Candidate Vaccine
by: Othman, Nurulhasanah
Published: (2006)

Development of novel vaccines against Enterovirus-71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)

Immunogenicity of soluble enterovirus 71 recombinant VP1 protein in mice model
by: Mustafa, Suhaili
Published: (2017)

Development of antivirals and vaccines against enterovirus 71 (EV-A71)
by: Poh, Chit Laa *
Published: (2018)

Development of a Deoxyribonucleic Acid Vaccine Against Enterovirus 71
by: Wong, Siew Tung
Published: (2005)

Bacteriophage as carrier for multiple DNA vaccine in poultry
by: Al-Tayyar, O. B., et al.
Published: (2015)

Evaluation of prime boosting vaccination strategy using newly constructed tuberculosis vaccine candidates in mice
by: Zakaria, Nurazwana
Published: (2013)

Synthesis of biodegradable polymer-mesoporous silica composite microspheres for DNA prime-protein boost vaccination
by: Ho, J., et al.
Published: (2010)

T Cell immunity to enterovirus 71 infection in humans and implications for vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2018)

Protective Efficacy Evaluation of NPt-NPt-VP1₁₋₁₀₀Protein as a Candidate Vaccine Against Enterovirus 71 Infections in Mouse Model
by: Ch'ng, Wei Choong
Published: (2010)

Factors affecting expression and solubility of Enterovirus 71 VP1 protein
by: Ahmad Hafad, Fathimah Azzahroh
Published: (2016)

Impact of genetic changes, pathogenicity and antigenicity on Enterovirus- A71 vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)

Development of novel miRNA-based vaccines and antivirals against Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)

Construction Of Recombinant BCG Expressing The VP1 Antigen Of Enterovirus 71 For The Development Of A Candidate Vaccine [QR186.87. N974 2007 f rb]
by: Othman, Nurulhasanah
Published: (2006)

The Nucleocapsid Protein Of Newcastle Disease Virus As A Carrier For The Vp1 Polypeptides Of Enterovirus 71
by: Sivasamugham, Lalita Ambigal
Published: (2005)

Immunogenicity of AHSV-4 VP7 crystals and their potential use as a vaccine delivery platform
by: Bailey, Laura Victoria
Published: (2016)

Development of a DNA vaccine against chicken anemia virus by using a bicistronic vector expressing VP1 and VP2 proteins of CAV.
by: Moeini, Hassan, et al.
Published: (2011)

Breaking the DNA-vaccine bottleneck
by: Danquah, Michael, et al.
Published: (2011)

Immunogenicity of recombinant mycobacterium smegmatis expressing antigen 85b epitopes as a potential tuberculosis vaccine candidate
by: Kadir , Nur Ayuni
Published: (2017)

Immunogenicity of a truncated enterovirus 71 VP1 protein fused to a Newcastle disease virus nucleocapsid protein fragment in mice.
by: Ch'ng, Wei Choong, et al.
Published: (2011)

Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes
by: Firouzamandi, Masoumeh, et al.
Published: (2016)

Construction of dna vaccine expressing msp-1c of plasmodium falciparum
by: Noraini, Mat Yunus
Published: (2008)

Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice
by: Yee, Isabel Pin Tsin *, et al.
Published: (2019)

Development of human enterovirus 71 nano calcium phosphate adjuvanted candidate vaccine for parenteral and mucosal delivery
by: Saeed Ahmed, Mohamed Ibrahim
Published: (2015)

Development and immunogenic potentials of chitosan-saponin encapsulated DNA vaccine against avian infectious bronchitis coronavirus
by: Bande, Faruku, et al.
Published: (2020)

Formaldehyde-Inactivated Whole-Virus Vaccine Protects a Murine Model of Enterovirus 71 Encephalomyelitis against Disease
by: Ong, Kien Chai, et al.
Published: (2010)

Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: A report of further observations
by: Longding, Liu, et al.
Published: (2015)

Immunogenicity of recombinant HS ABA392 DNA vaccine against Haemorrhagic septicaemia in animal model / Shamini Chelliah
by: Shamini , Chelliah
Published: (2018)

Limited immune response conferred by an E2-CSFV expressing DNA vaccine after booster vaccination in murine models
by: Allaudin, Zeenathul Nazariah, et al.
Published: (2009)

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host
by: Calvo-Pinilla, Eva, et al.
Published: (2018)

Improving DNA vaccine delivery and efficacy in poultry.
by: Omar, Abdul Rahman
Published: (2012)

Will the mRNA vaccines interfere with Oneâs DNA?
by: Mohd Nordin, Musa, et al.
Published: (2021)

Attenuated Salmonella typhimurium SV4089 as a potential carrier of oral DNA vaccine in chickens.
by: Jazayeri, Seyed Davoud, et al.
Published: (2012)

Rational design of live attenuated vaccine by site-directed mutagenesis and deletion in the 5’- non coding region of the enterovirus 71(EV-A71) genome
by: Yee, Isabel Pin Tsin *
Published: (2015)

In ovo vaccination against Newcastle disease virus using a DNA vaccine co-expressing the F and HN genes and dextran-spermin as a vehicle for DNA delivery
by: Firouzamandi, Masumeh, et al.
Published: (2013)

In vitro immunogenic and immunostimulatory effects of zwitterionized 23-valent pneumococcal polysaccharide vaccine compared with nonzwitterionized vaccine.
by: Abdulamir, Ahmed Sahib, et al.
Published: (2010)

Immunological studies of dna (pjwvacll) and surface display (r-stvacll) vaccine candidates expressing a synthetic mul tiepitope gene of mycobacterium tuberculosis in a prime boost strategy using a mouse model
by: Norhanani, Mohd Redzwan
Published: (2008)

Inhibition of Enterovirus 71 (EV-71 infections by a novel antiviral peptide derived from EV-71 capsid protein VP1
by: Tan, Chee Wah, et al.
Published: (2012)

Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: Recent epidemiology
by: Sheridan, S., et al.
Published: (2014)

Potential usefulness of viral capsid surface proteins (VP1,VP2, VP3 & VP4) for vaccination against common cold
by: Alshrari, Ahmed Subeh D
Published: (2016)